Healthcare Global Enterprises Ltd
NSE:HCG
Wall Street
Price Targets
HCG Price Targets Summary
Healthcare Global Enterprises Ltd
According to Wall Street analysts, the average 1-year price target for HCG is 445.01 INR with a low forecast of 393.9 INR and a high forecast of 495.6 INR.
Operating Income
Forecast
Operating Income Estimate
Healthcare Global Enterprises Ltd
For the last 8 years the compound annual growth rate for Healthcare Global Enterprises Ltd's operating income is 17%. The projected CAGR for the next 3 years is 27%.
Net Income
Forecast
Net Income Estimate
Healthcare Global Enterprises Ltd
For the last 8 years the compound annual growth rate for Healthcare Global Enterprises Ltd's net income is 57%. The projected CAGR for the next 3 years is 77%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HCG's stock price target?
Price Target
445.01
INR
According to Wall Street analysts, the average 1-year price target for HCG is 445.01 INR with a low forecast of 393.9 INR and a high forecast of 495.6 INR.
What is Healthcare Global Enterprises Ltd's Revenue forecast?
Projected CAGR
13%
For the last 8 years the compound annual growth rate for Healthcare Global Enterprises Ltd's revenue is 16%. The projected CAGR for the next 3 years is 13%.
What is Healthcare Global Enterprises Ltd's Operating Income forecast?
Projected CAGR
27%
For the last 8 years the compound annual growth rate for Healthcare Global Enterprises Ltd's operating income is 17%. The projected CAGR for the next 3 years is 27%.
What is Healthcare Global Enterprises Ltd's Net Income forecast?
Projected CAGR
77%
For the last 8 years the compound annual growth rate for Healthcare Global Enterprises Ltd's net income is 57%. The projected CAGR for the next 3 years is 77%.